Recital 4, Regulation (EU) 2017/1000

In forcesince 13 Jun 2017

On 8 September 2015, the Agency's Committee for Risk Assessment (‘RAC’) adopted its opinion concluding that subject to modification of the scope and conditions proposed in the Annex XV dossier, a general restriction on manufacture, use and placing on the market of PFOA, its salts and PFOA-related substances, is the most appropriate Union-wide measure to address the identified risks in terms of effectiveness in reducing those risks. RAC proposed two different concentration limits, namely 25 ppb for PFOA and its salts and 1000 ppb for one or a combination of PFOA-related substances, in other substances, mixtures or articles, reflecting the possible presence of unavoidable impurities and unintended contaminants, and taking account of the capabilities of analytical methods. RAC proposed to exempt from the restriction photographic coatings applied to films, papers or printing plates, implantable medical devices and substances or mixtures used in semiconductor and photolithography processes, considering the relatively low environmental impact and long substitution timeframes. RAC also proposed to exempt the use of substances as transported isolated intermediates in order to allow the manufacture of alternatives, as well as the placing on the market of second-hand articles.